We examined PRME and see fair value at $4.27 while it trades around $2.90 today, suggesting about 47.3% speculative upside. Our team flags it as a high‑risk, high‑reward opportunity. Will investors chase this gap? #PRME
September 25, 2026 at 11:32 PM
We examined PRME and see fair value at $4.27 while it trades around $2.90 today, suggesting about 47.3% speculative upside. Our team flags it as a high‑risk, high‑reward opportunity. Will investors chase this gap? #PRME
September 25, 2026 at 8:03 AM
#$PRME can now begin U.S. clinical testing of PM647, a one-time gene-editing treatment for alpha-1 antitrypsin deficiency. Initial results are expected in 2027, while #$BEAM remains further ahead in human trials. notreload.xyz/xy/prme-gets...
Prime Medicine Gets FDA Clearance to Test PM647 in AATD
First human data are due in 2027. This is not an approval; Beam remains ahead in patients.
notreload.xyz
September 24, 2026 at 9:03 PM
#$PRME can now begin U.S. clinical testing of PM647, a one-time gene-editing treatment for alpha-1 antitrypsin deficiency. Initial results are expected in 2027, while #$BEAM remains further ahead in human trials. notreload.xyz/xy/prme-gets...
$PRME gets FDA IND OK for PM647 to treat alpha-1 antitrypsin deficiency, clearing path for US trials and advancing prime-editing drugs. $GCTK $JAGX $HCWB $VKTX $ACAD $SRZN $DNA $ARTL $CYCN
www.biopharmcatalyst.com/news/2026/bi...
www.biopharmcatalyst.com/news/2026/bi...
Daily Updates 09/24/26
export-download.canva.com
September 24, 2026 at 8:30 PM
$PRME gets FDA IND OK for PM647 to treat alpha-1 antitrypsin deficiency, clearing path for US trials and advancing prime-editing drugs. $GCTK $JAGX $HCWB $VKTX $ACAD $SRZN $DNA $ARTL $CYCN
www.biopharmcatalyst.com/news/2026/bi...
www.biopharmcatalyst.com/news/2026/bi...
Prime Medicine (#$PRME): First In Vivo Prime Editing Trial Recruiting, PM647 Filing Window Runs to September 30
Free Biotech Catalyst Calendar on Merlintrader.
www.merlintrader.com/prime-medici...
Free Biotech Catalyst Calendar on Merlintrader.
www.merlintrader.com/prime-medici...
September 23, 2026 at 8:48 PM
Prime Medicine (#$PRME): First In Vivo Prime Editing Trial Recruiting, PM647 Filing Window Runs to September 30
Free Biotech Catalyst Calendar on Merlintrader.
www.merlintrader.com/prime-medici...
Free Biotech Catalyst Calendar on Merlintrader.
www.merlintrader.com/prime-medici...
Gene-editing shares fell after Anthropic said Claude found ART, a CRISPR-like enzyme system in phage DNA. Function unknown. #$EDIT, #$CRSP, #$NTLA, #$BEAM, #$PRME lower. notreload.xyz/xy/gene-edit...
Gene-Editing Stocks Slip After Anthropic CRISPR-Like Find
Early lab results show Claude found a CRISPR-like repeat array tied to a reverse transcriptase. No proven editing tool yet.
notreload.xyz
September 23, 2026 at 7:32 PM
I guess Target didn’t get the memo that the “We’re sooo sowwy we killed Optimus Prme” tour is in poor taste now, huh?
September 13, 2026 at 12:44 AM
I guess Target didn’t get the memo that the “We’re sooo sowwy we killed Optimus Prme” tour is in poor taste now, huh?
📰 #Finance
"MONTREAL, Sept. 10, 2026 (GLOBE NEWSWIRE) — Prime Drink Group Corp. (CSE: PRME) (“Prime” or the “Company”) announces that further to its news releases dated July 30, August 14 and August 27, 2026, the Company voluntarily applied for and the Company’s principal regulator,…"
"MONTREAL, Sept. 10, 2026 (GLOBE NEWSWIRE) — Prime Drink Group Corp. (CSE: PRME) (“Prime” or the “Company”) announces that further to its news releases dated July 30, August 14 and August 27, 2026, the Company voluntarily applied for and the Company’s principal regulator,…"
Prime Drink Group Provides Bi-Weekly MCTO Status Report
financialpost.com
September 10, 2026 at 10:17 PM
📰 #Finance
"MONTREAL, Sept. 10, 2026 (GLOBE NEWSWIRE) — Prime Drink Group Corp. (CSE: PRME) (“Prime” or the “Company”) announces a first closing of its previously announced non-brokered private placement offering of units of the Company (the “Unit Offering”) for gross proceeds of…"
"MONTREAL, Sept. 10, 2026 (GLOBE NEWSWIRE) — Prime Drink Group Corp. (CSE: PRME) (“Prime” or the “Company”) announces a first closing of its previously announced non-brokered private placement offering of units of the Company (the “Unit Offering”) for gross proceeds of…"
Prime Drink Group Announces First Closing of Private Placement
financialpost.com
September 10, 2026 at 12:39 PM
The point is, this team lacks grit, and it has for a long time. So when a headline came out this week saying "United need to learn to 'kill the hope'" it resonated with me. I watch a lot of prme games, and teams show up differently against us. They show up looking to slay a dragon.
/4
/4
September 9, 2026 at 10:09 PM
The point is, this team lacks grit, and it has for a long time. So when a headline came out this week saying "United need to learn to 'kill the hope'" it resonated with me. I watch a lot of prme games, and teams show up differently against us. They show up looking to slay a dragon.
/4
/4
Prime Medicine ($PRME): the first in vivo Prime Editing trial is recruiting in Auckland while the PM647 filing window runs to September 30
https://www.merlintrader.com/prime-medicine-stock-hub/
https://www.merlintrader.com/prime-medicine-stock-hub/
PRME Stock Hub: Can Prime Editing Cross The Clinical Gap?
PM577a, PM647, PM359, cash runway, going concern, dilution and the 2026–2027 evidence map—verified against primary sources.
www.merlintrader.com
September 6, 2026 at 3:25 AM
Prime Medicine ($PRME): the first in vivo Prime Editing trial is recruiting in Auckland while the PM647 filing window runs to September 30
https://www.merlintrader.com/prime-medicine-stock-hub/
https://www.merlintrader.com/prime-medicine-stock-hub/
Joan Brothers as a PRME Advocate Helps Advance Youth Innovation
rcnamericany.blogspot.com/2026/08/joan...
rcnamericany.blogspot.com/2026/08/joan...
Joan Brothers as a PRME Advocate Helps Advance Youth Innovation
rcnamericany.blogspot.com
August 28, 2026 at 5:14 PM
Joan Brothers as a PRME Advocate Helps Advance Youth Innovation
rcnamericany.blogspot.com/2026/08/joan...
rcnamericany.blogspot.com/2026/08/joan...
📰 #Finance
"MONTREAL, Aug. 27, 2026 (GLOBE NEWSWIRE) — Prime Drink Group Corp. (CSE: PRME) (“Prime” or the “Company”) announces that further to its news releases dated July 30 and August 14, 2026, the Company voluntarily applied for and the Company’s principal regulator, the British…"
"MONTREAL, Aug. 27, 2026 (GLOBE NEWSWIRE) — Prime Drink Group Corp. (CSE: PRME) (“Prime” or the “Company”) announces that further to its news releases dated July 30 and August 14, 2026, the Company voluntarily applied for and the Company’s principal regulator, the British…"
Prime Drink Group Provides Bi-Weekly MCTO Status Report
financialpost.com
August 27, 2026 at 10:07 PM
#SterlingPoint (Prme). Refrescante miniserie sobre relaciones familiares un tanto enrevesadas que engancha y entretiene. Se agradece que sea algo más bien ligero pero interesante, entre tanta serie intensa y larga o bien vacía e insulsa y con demasiaso relleno... Se ha confirmado 2a temporada.
August 24, 2026 at 6:55 PM
#SterlingPoint (Prme). Refrescante miniserie sobre relaciones familiares un tanto enrevesadas que engancha y entretiene. Se agradece que sea algo más bien ligero pero interesante, entre tanta serie intensa y larga o bien vacía e insulsa y con demasiaso relleno... Se ha confirmado 2a temporada.
BMO initiates #$PRME at Outperform/$9, citing its unique prime-editing tech that delivers precise DNA fixes without double-strand breaks. notreload.xyz/xy/bmo-outpe...
BMO Outperform on PRME for Differentiated Gene Editing
BMO cited Prime Medicine's unique prime-editing technology, which enables precise DNA corrections without creating double-strand breaks.
notreload.xyz
August 18, 2026 at 9:00 PM
BMO initiates #$PRME at Outperform/$9, citing its unique prime-editing tech that delivers precise DNA fixes without double-strand breaks. notreload.xyz/xy/bmo-outpe...
Wenn es draußen regnet und man dank des letzten Prme Days ein Laufband hat, dann gibt es halt ein Basis+Training. 35 Minuten bei 6:50/Min
#running #laufen #nevernotrunning
#running #laufen #nevernotrunning
August 18, 2026 at 8:28 PM
Wenn es draußen regnet und man dank des letzten Prme Days ein Laufband hat, dann gibt es halt ein Basis+Training. 35 Minuten bei 6:50/Min
#running #laufen #nevernotrunning
#running #laufen #nevernotrunning
#IsmuasSummerBreak
#MusicChallenge
August 1981
Level 42
Level 42
Love Games
The start of a wonderful decade
music.youtube.com/watch?v=prme...
#MusicChallenge
August 1981
Level 42
Level 42
Love Games
The start of a wonderful decade
music.youtube.com/watch?v=prme...
Level 42 - Love Games (1981) • TopPop
YouTube video by TopPop
music.youtube.com
August 18, 2026 at 7:42 PM
#IsmuasSummerBreak
#MusicChallenge
August 1981
Level 42
Level 42
Love Games
The start of a wonderful decade
music.youtube.com/watch?v=prme...
#MusicChallenge
August 1981
Level 42
Level 42
Love Games
The start of a wonderful decade
music.youtube.com/watch?v=prme...
📰 #Finance
"MONTREAL, Aug. 14, 2026 (GLOBE NEWSWIRE) — Prime Drink Group Corp. (CSE: PRME) (“Prime” or the “Company”) announces that further to its news release dated July 30, 2026, the Company voluntarily applied for and the Company’s principal regulator, the British Columbia…"
"MONTREAL, Aug. 14, 2026 (GLOBE NEWSWIRE) — Prime Drink Group Corp. (CSE: PRME) (“Prime” or the “Company”) announces that further to its news release dated July 30, 2026, the Company voluntarily applied for and the Company’s principal regulator, the British Columbia…"
Prime Drink Group Provides Bi-Weekly MCTO Status Report
financialpost.com
August 14, 2026 at 9:26 PM
⚠️ $PRME Prime Medicine/Cash Runway: Cash and investments declined sharply from $177.7M (Dec 2025) to $95.1M (June 2026), with H1 2026 operating cash burn of $83.8M. Stockholders' equity fell 67% to $39.8M. Runway extends only into 2027, necessitating futu...
August 6, 2026 at 2:30 PM
⚠️ $PRME Prime Medicine/Cash Runway: Cash and investments declined sharply from $177.7M (Dec 2025) to $95.1M (June 2026), with H1 2026 operating cash burn of $83.8M. Stockholders' equity fell 67% to $39.8M. Runway extends only into 2027, necessitating futu...
🚨 $PRME
On August 6, 2026, Prime Medicine, Inc. issued a press release announcing its financial results and business highlights for the quarter ended June 30, 2026. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information contained in Item 2.02 ...
On August 6, 2026, Prime Medicine, Inc. issued a press release announcing its financial results and business highlights for the quarter ended June 30, 2026. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information contained in Item 2.02 ...
SEC Filing: PRME
Click to view the official SEC document.
www.sec.gov
August 6, 2026 at 12:02 PM
🚨 $PRME
On August 6, 2026, Prime Medicine, Inc. issued a press release announcing its financial results and business highlights for the quarter ended June 30, 2026. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information contained in Item 2.02 ...
On August 6, 2026, Prime Medicine, Inc. issued a press release announcing its financial results and business highlights for the quarter ended June 30, 2026. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information contained in Item 2.02 ...
#PRME Prime Medicine Reports Second Quarter 2026 Financial Results and Provides Business Updates
https://www.stocktitan.net/news/PRME/prime-medicine-reports-second-quarter-2026-financial-results-and-8n22w87p32gl.html
https://www.stocktitan.net/news/PRME/prime-medicine-reports-second-quarter-2026-financial-results-and-8n22w87p32gl.html
Prime Medicine Reports Second Quarter 2026 Financial Results and Provides Business Updates
Prime Medicine (Nasdaq: PRME) reported second quarter 2026 results and pipeline progress, including IND and CTA clearances in the U.S. and New Zealand for PM577a in Wilson disease, establishing a global Phase 1/2 trial with startup underway and initial clinical data expected in 2027.The company obtained a favorable, binding arbitration outcome with Beam Therapeutics affirming Prime Medicine’s rights to PM647 in Alpha-1 Antitrypsin Deficiency and plans an IND/CTA filing in 3Q 2026. The FDA granted RMAT designation to PM359 in chronic granulomatous disease, and Prime Medicine is engaging toward a potential BLA submission in 1H 2027. R&D expenses fell to $33.4 million, G&A to $11.0 million, and net loss narrowed to $42.1 million. Cash, cash equivalents, investments, and restricted cash totaled $108.8 million as of June 30, 2026, which Prime Medicine expects will fund operations into 2027.
www.stocktitan.net
August 6, 2026 at 12:00 PM
#PRME Prime Medicine Reports Second Quarter 2026 Financial Results and Provides Business Updates
https://www.stocktitan.net/news/PRME/prime-medicine-reports-second-quarter-2026-financial-results-and-8n22w87p32gl.html
https://www.stocktitan.net/news/PRME/prime-medicine-reports-second-quarter-2026-financial-results-and-8n22w87p32gl.html
📰 #Finance
"MONTREAL, July 30, 2026 (GLOBE NEWSWIRE) — Prime Drink Group Corp. (CSE: PRME) (“Prime” or the “Company) announces that further to its press release dated June 12, 2026, it has extended its previously announced non-brokered private placement offering of units of the Company…"
"MONTREAL, July 30, 2026 (GLOBE NEWSWIRE) — Prime Drink Group Corp. (CSE: PRME) (“Prime” or the “Company) announces that further to its press release dated June 12, 2026, it has extended its previously announced non-brokered private placement offering of units of the Company…"
Prime Drink Group Extends Private Placement and Announces Delay in Filing Annual Financial Statements
financialpost.com
July 30, 2026 at 10:12 PM
📢 Appel à projets générique #AAPG 2026 : l’ANR publie la liste des projets sélectionnés pour financement (JCJC, PRME, PRC et PRCE) dans le cadre de l’ensemble des comités d’évaluation scientifique.
➡ anr.fr/fr/detail/ca...
➡ anr.fr/fr/detail/ca...
July 28, 2026 at 9:08 AM
📢 Appel à projets générique #AAPG 2026 : l’ANR publie la liste des projets sélectionnés pour financement (JCJC, PRME, PRC et PRCE) dans le cadre de l’ensemble des comités d’évaluation scientifique.
➡ anr.fr/fr/detail/ca...
➡ anr.fr/fr/detail/ca...
Full circle moment for UL academic, Professor Elaine Doyle, Professor of Taxation, as she accepts international teaching award in Egypt 👏💚🫶
#limerick #lovelimerick #limerickandproud #limerickcity #education
www.ilovelimerick.ie/professor-el...
#limerick #lovelimerick #limerickandproud #limerickcity #education
www.ilovelimerick.ie/professor-el...
Professor Elaine Doyle accepts international teaching award in Egypt
Meredith Storey, Senior Manager, PRME; Professor Elaine Doyle, Kemmy Business School, University of Limerick; David Steingard, Head of PRME Full circle moment for UL academic, Professor Elaine Doyle, ...
www.ilovelimerick.ie
July 27, 2026 at 11:20 AM
Full circle moment for UL academic, Professor Elaine Doyle, Professor of Taxation, as she accepts international teaching award in Egypt 👏💚🫶
#limerick #lovelimerick #limerickandproud #limerickcity #education
www.ilovelimerick.ie/professor-el...
#limerick #lovelimerick #limerickandproud #limerickcity #education
www.ilovelimerick.ie/professor-el...